Pfizer Ltd

Pfizer Ltd

Pfizer Ltd has announced a special window for re-lodgement of transfer and dematerialisation of physical securities, which were sold or purchased prior to April 1, 2019. The window is open from February 5, 2026, to February 4, 2027. Investors can submit their transfer deeds and documents to KFin Technologies Limited, the company's Registrar and Transfer Agent, to enable further processing and transfer of shares, if approved.

Pfizer Ltd

Pfizer Ltd's 75th Annual General Meeting was held on July 28, 2026, with a total of 1,05,890 shareholders on record. The meeting was attended by 46 shareholders through video conferencing, with 63.92% being promoters and 0.04% being public shareholders. The resolutions were passed with requisite majority, with all shareholders voting in favor of the resolutions.

Pfizer Ltd

Pfizer Ltd held its 75th Annual General Meeting on July 28, 2026, through video conferencing. The meeting was chaired by Mr. Pradip Shah, and the requisite quorum was present. The Chairman paid tribute to Late Mr. R.A. Shah, and the Members joined in observing a minute's silence. The proceedings of the meeting were recorded, and the video recording will be made available on the Company's website. The Members were provided the facility of remote e-voting on the resolutions proposed in the Notice of the Annual General Meeting.

Pfizer Ltd

Pfizer Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors at their meeting held on July 28, 2026. The results include a statement of unaudited financial results, which has been reviewed by the statutory auditors, B S R & Co. LLP.

Pfizer Ltd

Pfizer Ltd's Executive Director - Finance & Chief Financial Officer, Mr. Amit Agarwal, has resigned from the services of the company, effective October 8, 2026, to pursue an opportunity outside Pfizer Limited.